Molecular mechanisms of cardiac voltage-gated potassium channelopathies

被引:21
作者
Abbott, Geoffrey W.
机构
[1] Cornell Univ, Weill Med Coll, Dept Med, Greenberg Div Cardiol, New York, NY 10021 USA
[2] Cornell Univ, Dept Pharmacol, New York, NY 10021 USA
关键词
arrhythmia; hERG; I-Kr; KCNE; KCNQ1; Kv1.5; MinK; MiR1;
D O I
10.2174/138161206778522065
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Potassium channels form highly K+ ion-selective pores in the plasma membrane of excitable cells. Voltage-gated potassium (Kv) channels open in response to membrane depolarization to allow rapid diffusion of K+ ions out of the cell, thus repolarizing the cell to restore a negative resting membrane potential. Inherited mutations in Kv channel genes produce abnormal cellular repolarization and cause diseases of excitable tissues. Small molecule interactions with Kv channels can cause similar pathologies. During the last decade of research into Kv channels and associated diseases termed 'channelopathies' - we have begun to understand Kv channel function and dysfunction at the molecular level. In this review, the molecular mechanisms of Kv channelopathies are discussed, with particular emphasis on the overlap between inherited and acquired disease, and the drive towards novel channel-targeted therapies.
引用
收藏
页码:3631 / 3644
页数:14
相关论文
共 192 条
[1]
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia [J].
Abbott, GW ;
Sesti, F ;
Splawski, I ;
Buck, ME ;
Lehmann, WH ;
Timothy, KW ;
Keating, MT ;
Goldstein, SAN .
CELL, 1999, 97 (02) :175-187
[2]
Ethnic differences in cardiac potassium channel variants: Implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome [J].
Ackerman, MJ ;
Tester, DJ ;
Jones, GS ;
Will, ML ;
Burrow, CR ;
Curran, ME .
MAYO CLINIC PROCEEDINGS, 2003, 78 (12) :1479-1487
[3]
Modulation of A-type potassium channels by a family of calcium sensors [J].
An, WF ;
Bowlby, MR ;
Betty, M ;
Cao, J ;
Ling, HP ;
Mendoza, G ;
Hinson, JW ;
Mattsson, KI ;
Strassle, BW ;
Trimmer, JS ;
Rhodes, KJ .
NATURE, 2000, 403 (6769) :553-556
[4]
Pharmacogenetic considerations in diseases of cardiac ion channels [J].
Anantharam, A ;
Markowitz, SM ;
Abbott, GW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :831-838
[5]
Anson BD, 2005, LANCET, V365, P682, DOI 10.1016/S0140-6736(05)70936-3
[6]
A NEUTRAL AMINO-ACID CHANGE IN SEGMENT-IIS4 DRAMATICALLY ALTERS THE GATING PROPERTIES OF THE VOLTAGE-DEPENDENT SODIUM-CHANNEL [J].
AULD, VJ ;
GOLDIN, AL ;
KRAFTE, DS ;
CATTERALL, WA ;
LESTER, HA ;
DAVIDSON, N ;
DUNN, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :323-327
[7]
The cardiac sodium channel: Gating function and molecular pharmacology [J].
Balser, JR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (04) :599-613
[8]
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia [J].
Barbey, JT ;
Soignet, S .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (09) :842-842
[9]
K(v)LQT1 and IsK (minK) proteins associate to form the I-Ks cardiac potassium current [J].
Barhanin, J ;
Lesage, F ;
Guillemare, E ;
Fink, M ;
Lazdunski, M ;
Romey, G .
NATURE, 1996, 384 (6604) :78-80
[10]
Interactions between multiple phosphorylation sites in the inactivation particle of a K+ channel -: Insights into the molecular mechanism of protein kinase C action [J].
Beck, EJ ;
Sorensen, RG ;
Slater, SJ ;
Covarrubias, M .
JOURNAL OF GENERAL PHYSIOLOGY, 1998, 112 (01) :71-84